California just passed a health bill that aims to increase vaccination rates in schools and colleges against a sexually transmitted virus.  Lawmakers believe vaccination against HPV, or the human papillomavirus, will help reduce the risk of rare cancers five to 20 years down the line. But many parents are calling the bill deceptive. Testimonies during…

In part 1 and part 2 of this series, we discussed the HPV vaccine and its links to ovarian insufficiency and autoimmune disease. In part 3, we turn to questions regarding the effectiveness of the vaccine to prevent cervical cancer, and the limitations of relevant clinical trials to detect such a type of effect. Summary…

Quebec says it will start using human papillomavirus tests as its primary screening tool for cervical cancer, replacing the Pap smear. The Health Department says the province will systematically offer HPV testing for cervical cancer screening to all women aged 25 to 65, every five years. A government health-care research institute said in a January…

AstraZeneca said on Thursday its drug Imfinzi, along with chemoradiotherapy, failed to achieve the main goal of improving survival in patients with locally advanced cervical cancer without the disease worsening. The late-stage study, dubbed “CALLA,” tested progression-free survival of patients with the combination against chemoradiotherapy alone, the drugmaker said, and the results are seen as…